Cargando…

Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis

AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP h...

Descripción completa

Detalles Bibliográficos
Autores principales: Satiya, Jinendra, Mousa, Omar Y, Gupta, Kapil, Trivedi, Shivani, Oman, Sven P, Wijarnpreecha, Karn, Harnois, Denise M, Corral, Juan Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062114/
https://www.ncbi.nlm.nih.gov/pubmed/32166122
http://dx.doi.org/10.5114/ceh.2020.93054
_version_ 1783504489762783232
author Satiya, Jinendra
Mousa, Omar Y
Gupta, Kapil
Trivedi, Shivani
Oman, Sven P
Wijarnpreecha, Karn
Harnois, Denise M
Corral, Juan Enrique
author_facet Satiya, Jinendra
Mousa, Omar Y
Gupta, Kapil
Trivedi, Shivani
Oman, Sven P
Wijarnpreecha, Karn
Harnois, Denise M
Corral, Juan Enrique
author_sort Satiya, Jinendra
collection PubMed
description AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP has not been completely established. We aimed to determine the sensitivity and specificity of MRI/MRCP in the diagnosis of cholangiocarcinoma among patients with PSC from the published literature. MATERIAL AND METHODS: We searched Embase, PubMed, Cochrane, Scopus, ClinicalTrials.gov, and abstracts from relevant scientific meetings and performed a systematic review and meta-analysis to estimate the diagnostic yield of MRI/MRCP in patients with PSC. Sensitivity and specificity were calculated from pooled estimates of cholangiocarcinoma cases identified and lesions missed. Modifying variables were included in a meta-regression model. RESULTS: Our literature search yielded 302 articles and 9 conference abstracts; 8 studies involving 846 liver patients from 5 countries were included in the final analysis. Of those, 531 had PSC and received MRI/MRCP. Thirty-six (6.8%) patients were diagnosed with cholangiocarcinoma (33 true positive, 3 false negative and 1 false positive). Pooled sensitivity was 98.9% (95% CI: 98.6-99.3%). Cholangiocarcinoma cases missed by MRI/MRCP were diagnosed as beading irregularities of the central hepatic ducts, or PSC-related diffuse stricture. Metaregression revealed that neither publication year, study design, nor sample size had a significant effect on observed cancer rates (p = 0.9, 0.3, and 0.3, respectively). CONCLUSIONS: MRI/MRCP followed by endoscopic retrograde cholangiopancreatography (ERCP) is a sensitive and specific tool to diagnose cholangiocarcinoma among patients with PSC. Further research should estimate MRI/MRCP diagnostic accuracy for cholangiocarcinoma using prospective methodology and longer term outcomes.
format Online
Article
Text
id pubmed-7062114
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-70621142020-03-12 Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis Satiya, Jinendra Mousa, Omar Y Gupta, Kapil Trivedi, Shivani Oman, Sven P Wijarnpreecha, Karn Harnois, Denise M Corral, Juan Enrique Clin Exp Hepatol Original Paper AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP has not been completely established. We aimed to determine the sensitivity and specificity of MRI/MRCP in the diagnosis of cholangiocarcinoma among patients with PSC from the published literature. MATERIAL AND METHODS: We searched Embase, PubMed, Cochrane, Scopus, ClinicalTrials.gov, and abstracts from relevant scientific meetings and performed a systematic review and meta-analysis to estimate the diagnostic yield of MRI/MRCP in patients with PSC. Sensitivity and specificity were calculated from pooled estimates of cholangiocarcinoma cases identified and lesions missed. Modifying variables were included in a meta-regression model. RESULTS: Our literature search yielded 302 articles and 9 conference abstracts; 8 studies involving 846 liver patients from 5 countries were included in the final analysis. Of those, 531 had PSC and received MRI/MRCP. Thirty-six (6.8%) patients were diagnosed with cholangiocarcinoma (33 true positive, 3 false negative and 1 false positive). Pooled sensitivity was 98.9% (95% CI: 98.6-99.3%). Cholangiocarcinoma cases missed by MRI/MRCP were diagnosed as beading irregularities of the central hepatic ducts, or PSC-related diffuse stricture. Metaregression revealed that neither publication year, study design, nor sample size had a significant effect on observed cancer rates (p = 0.9, 0.3, and 0.3, respectively). CONCLUSIONS: MRI/MRCP followed by endoscopic retrograde cholangiopancreatography (ERCP) is a sensitive and specific tool to diagnose cholangiocarcinoma among patients with PSC. Further research should estimate MRI/MRCP diagnostic accuracy for cholangiocarcinoma using prospective methodology and longer term outcomes. Termedia Publishing House 2020-02-17 2020-02 /pmc/articles/PMC7062114/ /pubmed/32166122 http://dx.doi.org/10.5114/ceh.2020.93054 Text en Copyright: © 2020 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Satiya, Jinendra
Mousa, Omar Y
Gupta, Kapil
Trivedi, Shivani
Oman, Sven P
Wijarnpreecha, Karn
Harnois, Denise M
Corral, Juan Enrique
Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title_full Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title_fullStr Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title_full_unstemmed Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title_short Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
title_sort diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062114/
https://www.ncbi.nlm.nih.gov/pubmed/32166122
http://dx.doi.org/10.5114/ceh.2020.93054
work_keys_str_mv AT satiyajinendra diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT mousaomary diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT guptakapil diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT trivedishivani diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT omansvenp diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT wijarnpreechakarn diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT harnoisdenisem diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis
AT corraljuanenrique diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis